Insulin signalling and the regulation of glucose and lipid metabolism

Nature

Volumn 414, Issue 6865, 2001, Pages 799-806

  Saltiel, Alan R ^a   Kahn, C Ronald ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDEMIOLOGY; GLUCOSE; INSULIN; LIPIDS; MEDICAL PROBLEMS; SIGNALING; TISSUE;

DISORDERS;

METABOLISM;

INSULIN;

DIABETES; DISEASE RESISTANCE;

ATHEROSCLEROSIS; GLUCOSE METABOLISM; HORMONAL REGULATION; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOSE TISSUE; ANIMALS; CYTOSKELETAL PROTEINS; DIABETES MELLITUS, TYPE 2; GLUCOSE; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MICE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 0035856949     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/414799a     Document Type: Review

References (100)

1. Glucose transport and glucose transporters in muscle and their metabolic regulation
2. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
3. Adipose-selective targeting of the GLUT 4 gene impairs insulin action in muscle and liver
4. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
5. Tissue-specific knockout of the insulin receptorin pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes
6. The insulin receptor - A critical link in glucose homeostasis and insulin action
7. Tissue-specific versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology
8. Origin of insulin receptor-like tyrosine kinases in marine sponges
9. The IRS-signalling system: A network of docking proteins that mediate insulin action
10. Signaling pathways in insulin action: Molecular targets of insulin resistance
11. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
12. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene
13. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2
14. Disruption of IRS-2 causes type 2 diabetes in mice
15. Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis
16. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes
17. Stimulation of protein synthesis, cukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase
18. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair-IRS-1-and IRS-2-mediated signaling
19. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance
20. 14-3-3 (ε) interacts with the insulin-like growth factor I receptor and insulin-receptor substrate I in a phosphoserine-dependent manner
21. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ
22. Prevention of fat-induced insulin resistance by salicylate
23. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
24. Insulin stimulation glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: Evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S 6 kinase
25. IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domains of p85
26. The structure and function of p55P1K reveal a new regulatory subunit for phosphatidylinositol 3-kinase
27. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase muscle and brain
28. Structural organization and alternative splicing of the murine phosphoinositide 3-kinase p 85 alpha gene
29. Differential regulation of insulin receptor substrates-1 and-2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse
30. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p 85a
31. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3-kinase
32. Structural basis of 3-phosphoinositide recognition by pleckstrin homology domains
33. Diversification of cardiac insulin signaling involves the p85 alpha/beta subunits of phosphatidylinositol 3-kinase
34. Kinase phosphorylation: Keeping it all in the family
35. Rho GTPases
36. Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta
37. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha
38. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapimycin: Evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L 6 cells between Ras and Raf
39. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway
40. The activation of glycogen synthase by insulin switches from kinase inhibition to phosphatase activation during adipogenesis in 3T3-LI cells
41. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ)
42. Protein kinase C-as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport
43. The C. Elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway
44. Role of the Src homology 2 (SH2) domain and C-terminus tyrosine phosphorylation sites of SH2-containing inositol phosphatase (SHIP) in the regulation of insulin-induced mitogenesis
45. The lipid phosphatase SHIP2 controls insulin sensitivity
46. Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-LI adipocytes
47. A.role for CAP, a novel, multifunctional Src homology 3 domain-containing protein in formation of actin stress fibers and focal adhesions
48. Thiazolidinediones and insulin resistance: Peroxisome proliferator activated receptor gamma activation stimulates expression of the CAP gene
49. The sorbin homology domain: A motif for the targeting of proteins to lipid rafts
50. CAP defines a second signalling pathway required for insulin-stimulated glucose transport
51. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10
52. Lipid raft microdomain compartmentalization of TC10 is required for insulin signaling and GLUT4 translocation
53. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGE
54. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin
55. The target of rapamycin (TOR) proteins
56. Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation
57. TOR signalling and control of cell growth
58. The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila
59. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
60. The regulation of glycogen synthase by protein phosphatase I in 3T3-LI adipocytes. Evidence fora potential role for DARPP-32 in insulin action
61. Organizing glucose disposal: Emerging roles of the glycogen targeting subunits of protein phosphatase-1
62. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction
63. Free fatty acids and pathogenesis of type 2 diabetes mellitus
64. New concepts in extracellular signaling for insulin action: The single gateway hypothesis
65. Molecular physiology of the regulation of hepatic gluconeogenesis, and glycolysis
66. New connections in the regulation of PEPCK gene expression by insulin
67. Control of hepatic gluconcogenesis through the transcriptional coactivator PGC-1
68. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes
69. ADD1/SREBP- 1c is required in the activation of hepatic lipogenic gene expression by glucose
70. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice
71. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isopraterenol and govern activation properties in vitro
72. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt
73. Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle
74. Syndromes associated with insulin resistance and acanthosis nigricans
75. Strategies and prospects for finding insulin resistance genes
76. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-I null alleles
77. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-I and βcell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease
78. Altered function of insulin receptor substrate-I-deficient mouse islets and cultured beta-cell lines
79. Role of brain insulin receptor in control of body weight and reproduction
80. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin-uses resistance and glucose intolerance
81. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4
82. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle
83. Cellular mechanisms of insulin resistance
84. Regional differences in intramyocellular lipids in humans observed by in vivo IH-MR spectroscopic imaging
85. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
86. Targeted disruption of the tumor necrosis factor-alpha gene: Metabolic consequences in obese and nonobese mice
87. Effects of an engineered human anti-TNF-alpha antibody (SDP571) on insulin sensitivity and glycemic control in patients with NIDDM
88. Weight-reducing effects of the plasma protein encoded by the obese gene
89. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
90. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia
91. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice
92. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
93. The adipocyte-secreted protein Acrp 30 enhances hepatic insulin action
94. Genomewide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24
95. A family of tissue-specific resistin-like molecules
96. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal musde
97. Targeted gene mutations define the roles of insulin and IGF-I receptors in mouse embryonic development
98. Dual roles for glucokiliase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase
99. Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location! Location!
100. Perinuclear localization and insulin responsiveness of GLUT4 requires cytoskeletal integrity in 3T3-LI adipocytes